In 2023, Novo Nordisks Ozempic and Wegovy generated $13.9 billion and $4.6 billion, respectively, while Eli Lillys Trulicity and Mounjaro generated $7.1 billion and $5.1 billion. By 2030, Eli Lilly is expected to surpass Novo Nordisk, becoming the leading company in GLP-1R sales with $67.7 billion
Ozkul B, Sever H, Yiittrk G, Elgrm S, Gr SG, Erba O
Potential Research Applications: Growth hormone secretion and endocrine studies Muscle growth, recovery, and anti-aging research models Fat metabolism and body composition studies GH axis and pituitary function investigations For laboratory research only
FAQ 8: What Role Does GPx Play in Reproductive Health
Taking semaglutide at the optimal time and choosing the best time for tirzepatide can help maintain consistent drug levels